These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31365429)

  • 1. Outcomes of intermediate-risk to high-risk stage I endometrial cancer: 10-year clinical experiences of using in-house multi-channel applicators in a single center.
    Hou XR; Yu L; Hu K; Zhang FQ
    Chin Med J (Engl); 2019 Aug; 132(16):1935-1941. PubMed ID: 31365429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
    Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
    BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.
    Ozgul N; Boyraz G; Salman MC; Gultekin M; Yuce K; Ibrahimov A; Erturk A; Gungorduk K; Gulseren V; Sanci M; Turkmen O; Karalok A; Kimyon G; Turan T; Ozkan NT; Meydanli MM; Gungor T; Ayik H; Simsek T
    Int J Gynecol Cancer; 2018 Jan; 28(1):161-167. PubMed ID: 28930810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal brachytherapy for endometrial cancer.
    Hass P; Seinsch S; Eggemann H; Ignatov T; Seitz S; Ignatov A
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1523-1530. PubMed ID: 29730776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
    Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
    Greven KM; D'Agostino RB; Lanciano RM; Corn BW
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):101-4. PubMed ID: 9747826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
    Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
    Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified Under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results From a Single Institution.
    Kumar UP; Yathiraj PH; Sharan KT; Kamath A; Singh A; Reddy SA; Alurkar P; Fernandes DJ; Mamidipudi VS
    Int J Gynecol Cancer; 2018 Jun; 28(5):854-860. PubMed ID: 29683879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China.
    Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
    BMC Womens Health; 2023 Aug; 23(1):417. PubMed ID: 37553639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy.
    Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1366-72. PubMed ID: 12873682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model.
    Ren K; Wang W; Sun S; Hou X; Hu K; Zhang F
    Cancer Med; 2022 Jan; 11(1):257-267. PubMed ID: 34779587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.